Nigeria, March 4 -- The National Agency for Food and Drug Administration and Control (NAFDAC) has announced an immediate halt to the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension in Nigeria.

The agency, in a statement on Monday, explained that the decision was made due to the instability of the drug after it is mixed with water.

This instability reduces its effectiveness over time, making it unsafe for treating malaria.

The ban applies to all brands of the medication, whether produced locally or imported.

NAFDAC confirmed that it will no longer approve new applications, renew existing registrations, or make changes to the product's status.

According to NAFDAC, studies have shown tha...